Ruben Abagyan
6Patents
1h-index
24Co-inventors
47Inventor score
Filing activity: Apr 18, 2008 → Mar 18, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9737525B2 | Small molecule activators of NRF2 pathway | Human Necessities | 1 | Active |
| US11697650B2 | Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors | Human Necessities | 0 | Active |
| US11834450B2 | Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8961987B2 | Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies | Chemistry; Metallurgy | 0 | Active |
| US11919880B2 | HCV protease inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8394811B2 | Hydrazide compounds as thyroid hormone receptor modulators and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.